Topics

Articles

The ‘broken promise’ of lower-cost insulin, according to Senators Warren and Blumenthal

Higher inventory turns, lower inventories—but lower profit margins, too

Change.org touts its influence in the decision

Dealing with pharma’s commercial data deluge

Licensing for Gilead’s Truvada and Descovy products is in question

Action expands Pharma Logistics’ leadership in servicing independent pharmacies

Task force report highlights the economic disincentives of short-supply products

Upstart organization seeks to create another pathway for acceptance by regulators and pharmacy benefit managers

Analysis of its members’ covered lives show the effect of expensive specialty drugs on insurance plans